Evidence map›Paper›PMID 37524934›Full record

ArticleSkeletal radiology2024

Sclerosing epithelioid fibrosarcoma of bone with hybrid features: clinicopathologic, radiologic, and molecular analysis of three cases.

David I Suster, John M Gross, Laura Fayad, Cornelia Wenokor, Jeffrey D Goldsmith, Ashley Ward, Caroline Early, Santiago Lazano-Calderon, Michael J Klein

Abstract read
PubMed Publisher
In one paragraph

Article in Skeletal radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

David I SusterDepartment of Pathology, Rutgers University New Jersey Medical School, 150 Bergen Street, Newark, NJ, 07103, USA. dis49@njms.rutgers.edu.ORCID http://orcid.org/0000-0002-7986-4340
John M GrossDepartment of Pathology, John Hopkins University School of Medicine, Baltimore, MD, USA.
Laura FayadDepartment of Radiology, Orthopaedic Surgery and Oncology, John Hopkins University School of Medicine, Baltimore, MD, USA.
Cornelia WenokorDepartment of Radiology, Rutgers University New Jersey Medical School, Newark, NJ, USA.
Jeffrey D GoldsmithDepartment of Pathology, Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA, USA.
Ashley WardDepartment of Pathology, Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA, USA.
Caroline EarlyDepartment of Pathology, John Hopkins University School of Medicine, Baltimore, MD, USA.
Santiago Lazano-CalderonDepartment of Surgery, Massachusetts General Hospital Harvard Medical School, Boston, MA, USA.
Michael J KleinDepartment of Pathology, Hospital for Special Surgery, New York, NY, USA.
Johns Hopkins University · USBeth Israel Deaconess Medical Center · USRutgers, The State University of New Jersey · USHarvard University · USHospital for Special Surgery · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sclerosing epithelioid fibrosarcoma (SEF) occurring as a primary bone tumor is exceptionally uncommon. Even more rare are cases of SEF that show morphologic overlap with low-grade fibromyxoid sarcoma (LGFMS). Such hybrid lesions arising within the bone have only rarely been reported in the literature. Due to their variegated histomorphology and non-specific radiologic features, these tumors may pose diagnostic difficulties. Herein we describe three molecularly confirmed primary bone cases of sclerosing epithelioid fibrosarcoma that demonstrated prominent areas showing the features of LGFMS and with areas resembling so-called hyalinizing spindle cell tumor with giant rosettes (HSCTGR). Two patients were female and one was male aged 26, 47, and 16, respectively. The tumors occurred in the femoral head, clavicle, and temporal bone. Imaging studies demonstrated relatively well-circumscribed radiolucent bone lesions with enhancement on MRI. Cortical breakthrough and soft tissue extension were present in one case. Histologically the tumors all demonstrated hyalinized areas with SEF-like morphology as well as spindled and myxoid areas with LGFMS-like morphology. Two cases demonstrated focal areas with rosette-like architecture as seen in HSCTGR. The tumors were all positive for MUC4 by immunohistochemistry and cytogenetics, fluorescence in-situ hybridization, and next-generation sequencing studies identified EWSR1 gene rearrangements confirming the diagnosis in all three cases.Hybrid SEF is exceedingly rare as a primary bone tumor and can be difficult to distinguish from other low-grade spindled and epithelioid lesions of bone. MUC4 positivity and identification of underlying EWSR1 gene rearrangements help support this diagnosis and exclude other tumor types.

Indexed as

Bone NeoplasmsFibrosarcomaMyxosarcomaSoft Tissue NeoplasmsBiomarkers, TumorFemaleHumansImmunohistochemistryMaleBiomarkers, TumorBone tumorCREB3L1EWSR1Hybrid sclerosing epithelioid fibrosarcomaLow-grade fibromyxoid sarcoma

Identifiers

PMID37524934
OpenAlexW4385430105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.